跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,630 条关于
“Accord Healthcare Limited”
全部
24,630
临床试验
6,875
药物
376
机构
1,740
资讯
15,639
3个月前
Sakar Healthcare Expands Oncology Reach with Zydus Lifesciences Partnership for GCC Markets
去年
MHRA Approves Serplulimab as First Anti-PD-1 Therapy for Small Cell Lung Cancer in UK
去年
European Commission Approves Accord Healthcare's Ustekinumab Biosimilar, Imuldosa
5个月前
Accord BioPharma's Ustekinumab Biosimilar IMULDOSA Gains Preferred Status on Cigna Healthcare Formularies
去年
Accord Healthcare Secures Positive CHMP Opinion for Denosumab Biosimilars Targeting Osteoporosis and Oncology
去年
Accord BioPharma Launches IMULDOSA Biosimilar at 92% Discount to STELARA
去年
FDA Approves Accord BioPharma's IMULDOSA (Ustekinumab-srlf) as Biosimilar
2年前
Accord BioPharma's Hercessi (trastuzumab-strf) Receives FDA Approval for 420mg Strength
去年
Intas Pharmaceuticals and Accord BioPharma Acquire UDENYCA Biosimilar, Expanding Global Pegfilgrastim Market Presence
10个月前
FDA Approves Accord BioPharma's Denosumab Biosimilars OSVYRTI and JUBEREQ for Bone Disorders
第 1 页,共 1564 页
上一页
下一页